The on-treatment resection tissue demonstrated diffuse CD8 infiltration colocalized with a strong IgG4 signal, along with minimal PD-1 signal, demonstrating PD-1 receptor target engagement on cytotoxic CD8+ T cells by nivolumab in the tumor (Fig. 2A and B). Here, CD8A is linked to neoplasm.